Jared Gollob

Companies

• Kymera TherapeuticsChief Medical Officer Aug 20, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKymera Therapeutics KYMR117,134 shares²$12.7M at $108.14Mar 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 4, 2026Sold 447 shares at $86.62 of Kymera Therapeutics²
• Mar 4, 2026Sold 1,437 shares at $85.78 of Kymera Therapeutics²
• Mar 4, 2026Sold 2,519 shares at $85.04 of Kymera Therapeutics²
• Mar 4, 2026Sold 492 shares at $84.00 of Kymera Therapeutics²
• Mar 2, 2026Sold 3,048 shares at $89.66 of Kymera Therapeutics²
• Mar 2, 2026Sold 1,055 shares at $88.50 of Kymera Therapeutics²
• Mar 2, 2026Sold 1,510 shares at $87.75 of Kymera Therapeutics²
• Mar 2, 2026Granted 17,650 shares of Kymera Therapeutics²
• Dec 8, 2025Sold 1,400 shares at $92.19 of Kymera Therapeutics³
• Dec 8, 2025Sold 3,300 shares at $91.46 of Kymera Therapeutics³
• Dec 8, 2025Sold 8,562 shares at $90.12 of Kymera Therapeutics³
• Dec 8, 2025Sold 3,929 shares at $89.43 of Kymera Therapeutics³
• Dec 8, 2025Sold 18,357 shares at $88.02 of Kymera Therapeutics³
• Dec 8, 2025Sold 13,759 shares at $87.37 of Kymera Therapeutics³
• Dec 8, 2025Exercised options 49,307 shares at $5.33 of Kymera Therapeutics³
• Oct 15, 2025Sold 6,453 shares at $63.09 of Kymera Therapeutics⁴
• Oct 15, 2025Sold 14,896 shares at $62.72 of Kymera Therapeutics⁴
• Oct 15, 2025Sold 8,963 shares at $61.49 of Kymera Therapeutics⁴
• Oct 15, 2025Sold 29,264 shares at $60.37 of Kymera Therapeutics⁴
• Oct 15, 2025Exercised options 22,210 shares at $2.08 of Kymera Therapeutics⁴
• Oct 15, 2025Exercised options 28,999 shares at $1.31 of Kymera Therapeutics⁴
• Oct 13, 2025Sold 3,114 shares at $60.00 of Kymera Therapeutics⁵
• Oct 13, 2025Exercised options 673 shares at $2.08 of Kymera Therapeutics⁵
• Oct 13, 2025Exercised options 800 shares at $1.31 of Kymera Therapeutics⁵
• Mar 3, 2025Sold 1,045 shares at $31.00 of Kymera Therapeutics⁶